Literature DB >> 25824071

Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathways.

Petros Perros1, Colin M Dayan2, A Jane Dickinson3, Daniel Ezra4, Stephanie Estcourt5, Peter Foley6, Janis Hickey7, John H Lazarus8, Caroline J MacEwen9, Julie McLaren10, Geoffrey E Rose11, Jimmy Uddin11, Bijay Vaidya12.   

Abstract

Graves' orbitopathy (GO) is uncommon, but responsible for considerable morbidity. A coordinated approach between healthcare professionals is required in order to meet the needs of patients. Early diagnosis can be achieved by a simple clinical assessment. Low-cost effective interventions can be initiated by generalists, which may improve outcomes. Moderate-to-severe GO should be referred to specialised centres. Recommendations for clinical diagnosis, initial management and referral pathways are highlighted.
© 2015 Royal College of Physicians.

Entities:  

Keywords:  Graves’ orbitopathy; guidance; referral pathways; thyroid eye disease

Mesh:

Year:  2015        PMID: 25824071      PMCID: PMC4953738          DOI: 10.7861/clinmedicine.15-2-173

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  4 in total

1.  Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration.

Authors:  Annika S Quinn; Leticia R Dujardin; Bridget Knight; James Benzimra; Anthony G Quinn; Bijay Vaidya
Journal:  Int Ophthalmol       Date:  2017-02-08       Impact factor: 2.031

2.  The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.

Authors:  Luigi Bartalena; Lelio Baldeschi; Kostas Boboridis; Anja Eckstein; George J Kahaly; Claudio Marcocci; Petros Perros; Mario Salvi; Wilmar M Wiersinga
Journal:  Eur Thyroid J       Date:  2016-03-02

3.  Prognostic indicators for the development of strabismus among patients with graves' ophthalmopathy.

Authors:  Tiffany Y Lin; Ning Li; Michael W Yeh; Angela M Leung; Daniel B Rootman
Journal:  J Clin Transl Endocrinol       Date:  2017-07-11

4.  Preclinical studies on the toxicology, pharmacokinetics and safety of K1-70TM a human monoclonal autoantibody to the TSH receptor with TSH antagonist activity.

Authors:  Jadwiga Furmaniak; Jane Sanders; Jill Clark; Jane Wilmot; Paul Sanders; Yang Li; Bernard Rees Smith
Journal:  Auto Immun Highlights       Date:  2019-11-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.